Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-7-9
pubmed:abstractText
CSF-1 and TNF-alpha in the kidney of MRL-Fas(lpr) mice are proximal events that precede and promote autoimmune lupus nephritis, while apoptosis of renal parenchymal cells is a feature of advanced human lupus nephritis. In the MRL-Fas(lpr) kidney, infiltrating T cells that secrete IFN-gamma are a hallmark of disease. To examine the impact of IFN-gamma on renal injury in MRL-Fas(lpr) mice, we constructed a IFN-gamma R-deficient strain. In MRL-Fas(lpr) mice lacking IFN-gamma R, circulating and intrarenal CSF-1 were absent, TNF-alpha was markedly reduced, survival was extended, lymphadenopathy and splenomegaly were prevented, and the kidneys remained protected from destruction. Mesangial cells (MC) that were signaled through the IFN-gamma R induced CSF-1 and TNF-alpha in MRL-Fas(lpr) mice. We detected a large number of apoptotic renal parenchymal cells in advanced nephritis and determined that signaling via the IFN-gamma R induces apoptosis of tubular epithelial cells (TEC), but not MC. By comparison, TNF-alpha induces apoptosis in MC, but not TEC, of the MRL-Fas(lpr) strain. Thus, IFN-gamma is directly and indirectly responsible for apoptosis of TEC and MC in MRL-Fas(lpr) mice, respectively. In conclusion, IFN-gamma R signaling is essential for the initiation (CSF-1), acceleration (CSF-1 and TNF-alpha), and apoptotic destruction of renal parenchymal cells in MRL-Fas(lpr) autoimmune kidney disease.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
161
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
494-503
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9647261-Animals, pubmed-meshheading:9647261-Antigens, CD95, pubmed-meshheading:9647261-Apoptosis, pubmed-meshheading:9647261-Autoimmune Diseases, pubmed-meshheading:9647261-Cell Death, pubmed-meshheading:9647261-Down-Regulation, pubmed-meshheading:9647261-Epithelial Cells, pubmed-meshheading:9647261-Glomerular Mesangium, pubmed-meshheading:9647261-Interferon-gamma, pubmed-meshheading:9647261-Kidney, pubmed-meshheading:9647261-Kidney Function Tests, pubmed-meshheading:9647261-Kidney Tubules, pubmed-meshheading:9647261-Lupus Nephritis, pubmed-meshheading:9647261-Lymphatic Diseases, pubmed-meshheading:9647261-Macrophage Colony-Stimulating Factor, pubmed-meshheading:9647261-Mice, pubmed-meshheading:9647261-Mice, Inbred C57BL, pubmed-meshheading:9647261-Mice, Inbred MRL lpr, pubmed-meshheading:9647261-Mice, Inbred Strains, pubmed-meshheading:9647261-Mice, Knockout, pubmed-meshheading:9647261-Receptors, Interferon, pubmed-meshheading:9647261-Signal Transduction, pubmed-meshheading:9647261-Splenomegaly, pubmed-meshheading:9647261-Tumor Necrosis Factor-alpha
pubmed:year
1998
pubmed:articleTitle
IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
pubmed:affiliation
Renal Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't